Skip to main content

Carcinogenesis of Biliary Tract in Pancreaticobiliary Maljunction

  • Chapter
  • First Online:
Pancreaticobiliary Maljunction and Congenital Biliary Dilatation
  • 314 Accesses

Abstract

Pancreaticobiliary maljunction (PBM) is a high-risk factor for biliary tract cancer. Because of the excessive length of the common channel in PBM, sphincter action does not directly affect the pancreaticobiliary junction, which allows pancreatic juice to reflux into the biliary tract. The refluxed pancreatic juice injures the epithelium of the biliary tract and promotes the development of the cancer. Indeed, a nationwide survey in Japan revealed that biliary cancers were detected in 21.6 and 42.4% of PBM patients with and without biliary dilatation, respectively. The mechanism of carcinogenesis in PBM is considered to be the “hyperplasia-dysplasia-carcinoma sequence” which differs from the usual biliary carcinogenesis (the “adenoma-carcinoma sequence” or “de novo carcinogenesis”) in the population without PBM. Hyperplastic changes of the biliary epithelium were observed even in children with PBM, and the Ki-67 labeling index was higher. Several gene mutations were reported to be related in biliary carcinogenesis of PBM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20(5):472–80.

    Article  PubMed  Google Scholar 

  2. Shimada K, Yanagisawa J, Nakayama F. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology. 1991;13(3):438–44.

    Article  PubMed  CAS  Google Scholar 

  3. Funabiki T, Sugiue K, Matsubara T, Amano H, Ochiai M. Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J Med. 1991;40(3):118–22.

    Article  PubMed  CAS  Google Scholar 

  4. Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50(10):2226–34.

    Article  PubMed  CAS  Google Scholar 

  5. Watanabe H, Date K, Itoi T, Matsubayashi H, Yokoyama N, Yamano M, et al. Histological and genetic changes in malignant transformation of gallbladder adenoma. Ann Oncol. 1999;10(Suppl 4):136–9.

    Article  PubMed  Google Scholar 

  6. Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg/Deutsche Gesellschaft fur Chirurgie. 2001;386(3):224–9.

    Article  CAS  Google Scholar 

  7. Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Ishimaru S, et al. Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol. 1996;91(5):1007–11.

    CAS  PubMed  Google Scholar 

  8. Yamamoto M, Nakajo S, Tahara E, Ito M, Taniyama K, Shimamoto F, et al. Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. Pathol Res Pract. 1991;187(2–3):241–6.

    Article  CAS  PubMed  Google Scholar 

  9. Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, et al. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer. 1998;83(2):267–75.

    Article  PubMed  CAS  Google Scholar 

  10. Tokiwa K, Ono S, Iwai N. Mucosal cell proliferation activity of the gallbladder in children with anomalous arrangement of the pancreaticobiliary duct. J Hepato-Biliary-Pancreat Surg. 1999;6(3):213–7.

    Article  CAS  Google Scholar 

  11. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer. 1996;77(3):452–8.

    Article  PubMed  CAS  Google Scholar 

  12. Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M, Funabiki T. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 2002;9(3):312–21.

    Article  Google Scholar 

  13. Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch surg/Deutsche Gesellschaft fur. Chirurgie. 2009;394(1):159–69.

    Article  Google Scholar 

  14. Matsubara T, Funabiki T, Jinno O, Sakurai Y, Hasegawa S, Imazu H, et al. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. J Hepato-Biliary-Pancreat Surg. 1999;6(3):286–93.

    Article  CAS  Google Scholar 

  15. Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg. 2002;26(1):91–8.

    Article  PubMed  Google Scholar 

  16. Kamisawa T, Kuruma S, Chiba K, Tabata T, Koizumi S, Kikuyama M. Biliary carcinogenesis in pancreaticobiliary maljunction. J Gastroenterol. 2017;52(2):158–63.

    Article  PubMed  CAS  Google Scholar 

  17. Yamato T, Kurumaya H, Ohama K, Yamamichi N, Watanabe Y, Harada K, et al. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction. Liver. 1999;19(4):281–7.

    Article  PubMed  CAS  Google Scholar 

  18. Tsuchida A, Nagakawa Y, Kasuya K, Itoi T, Endo M, Ozawa T, et al. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction. Oncol Rep. 2003;10(2):339–43.

    PubMed  CAS  Google Scholar 

  19. Tsuchida A, Itoi T, Kasuya K, Endo M, Katsumata K, Aoki T, et al. Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N-nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters. Carcinogenesis. 2005;26(11):1922–8.

    Article  CAS  PubMed  Google Scholar 

  20. Ichikawa Y, Kamiyama M, Sekido H, Ishikawa T, Miura Y, Kamiya N, et al. Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study. J Hepato-Biliary-Pancreat Surg. 2004;11(1):34–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keigo Yada .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yada, K., Mori, H., Ishibashi, H., Shimada, M. (2018). Carcinogenesis of Biliary Tract in Pancreaticobiliary Maljunction. In: Kamisawa, T., Ando, H. (eds) Pancreaticobiliary Maljunction and Congenital Biliary Dilatation. Springer, Singapore. https://doi.org/10.1007/978-981-10-8654-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-8654-0_21

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-8653-3

  • Online ISBN: 978-981-10-8654-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics